Atrial Appendage Occluder Market Share 2022 to 2032 | By Appriva Medical, Abbott, SentreHEART, Coherex Medical

The Atrial Appendage Occluder market size was valued at US$ 854.6 million in 2022 and is projected to grow at an astounding double-digit CAGR of 23.95% to reach US$ 7,316.9 million by the end of the forecast period (2022 to 2032).

The left atrial appendage (LAA), also known as the atrial appendage, is a pouch resembling an ear located in the upper left chamber of the human heart, the left atrium. Despite its structure, the function of LAA remains unclear. However, individuals with arrhythmic cardiovascular conditions, such as atrial fibrillation, can experience blood accumulation in the LAA, leading to the formation of blood clots that may result in fatal strokes if they enter the bloodstream.

Get Full PDF Sample Copy of Latest Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-4049

To prevent such complications, an alternative approach besides oral anticoagulants is to use an occluder to permanently close off the LAA. Atrial appendage occlusion, which involves the placement of a plug in the appendage, is a viable option for safeguarding the cardiovascular health of patients.

A recent study published in the journal Clinical Medical Insights: Cardiology indicated that atrial fibrillation affects approximately 2 percent of the global population, with the incidence of the disease expected to rise fivefold over the next four decades, particularly in the United States due to its expanding elderly population.

Atrial Appendage Occluder Market: Drivers and Restraints

The global market for Atrial Appendage Occluders is primarily fueled by the growing number of cardiovascular patients diagnosed with thromboembolism and atrial fibrillation worldwide. Additionally, sedentary lifestyles and related conditions like diabetes, obesity, and hypertension have increased the demand for such devices, creating a pathway for market expansion.

However, the limited use of LAA occluders for patients with a high stroke and bleeding risk while on anticoagulant therapy may impede market growth. Furthermore, the implantation and removal of the device can cause complications such as tissue erosion, which can require open-heart surgery, acting as a limiting factor for market growth. Additionally, unfavorable policies concerning endocardial LAA closure have also restricted market growth.

Contact Us for a Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-4049

Atrial Appendage Occluder Market: Overview

The global Atrial Appendage Occluder market is extremely consolidated, with only a few players. Annually, roughly 15 million strokes occur worldwide, according to the World Health Organisation (WHO). In 2010, the United States spent around USD 53.9 billion on health care services, drugs, and lost work days due to a heart stroke.

Ischemic strokes account for approximately 87% of all strokes, which occur when blood circulation to the brain is compromised. Stroke is third among leading causes of mortality, and it is also the leading cause of long-term disability. Around 20% of ischemic strokes are caused by atrial fibrillation.

Atrial Appendage Occluder Market: Region-wise Outlook

The Atrial Appendage Occluder Market is geographically segmented into North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and the Middle East and Africa. The North American market is currently leading the global market, primarily due to its large population of elderly individuals.

Atrial Appendage Occluder Market: Key Players

The key players in the global Atrial Appendage Occluder Market include Appriva Medical Inc., Boston Scientific, St. Jude Medical, SentreHEART Inc, pfm medical ag., Occlutech, W. L. Gore & Associates, Inc., Cardia, Inc. and AtriCure, Inc.

Request Report Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-4049

Key Segments Profiled In The Atrial Appendage Occluder Industry Survey

Type of indication:

• Non-valvular Atrial Fibrillation

Procedure of positioning of the device:

• Endocardial
• Epicardial

End user:

• Hospitals
• Clinics

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs